APOSENSE
Aposense (formerly NST) is a clinical-stage molecular imaging and drug development company, with a pipeline of products based on its patented platform technology for targeting apoptosis (programmed cell death) in vivo. The company translating the science of Apoptosis (programmed cell death) into personalized patient care in multiple disease categories, including oncology, cardiology, and neurology. Targeting of this important biological process in-vivo opens opportunities for real-time clinical ... imaging of disease activity and targeted therapy. Aposense specializing in the development of novel drugs and utilizing membrane electrical forces for trans-membrane of macromolecule drugs, mainly siRNA. It also developed rationally-designed molecular nano-motors (MNMs), being novel small-molecule chemical entities and its translation into kinetic energy for movement within the hydrophobic membrane core. Aposense was founded in 1996 and is headquartered in Petah Tiqva, HaMerkaz, Israel.
APOSENSE
Social Links:
Industry:
Biotechnology Health Care Medical Pharmaceutical
Founded:
1996-01-01
Address:
Petah Tiqva, HaMerkaz, Israel
Country:
Israel
Website Url:
http://www.aposense.com
Total Employee:
11+
Status:
Active
Contact:
+ 972.73.239.7600
Email Addresses:
[email protected]
Total Funding:
22.3 M USD
Technology used in webpage:
Google Maps Person Schema Gravatar Profiles Israeli Server Location
Similar Organizations
BionPharma
BionPharma develops and commercializes affordable quality generics and builds strong and effective partnerships.
Celator Pharmaceuticals
Celator Pharmaceuticals is a biopharmaceutical company developing therapies to treat cancer, using the drug ratio technology platform.
Phoenix Eagle
Phoenix Eagle is a biopharmaceutical research, development company with a robust product pipeline based on its unique OPAL technology.
Soiken
Soiken is a biomarker and bioassay development and research company.
Tivorsan Pharmaceuticals
Tivorsan Pharmaceuticals is a protein therapeutics company that focuses on treating neuromuscular disorders.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
Ziegler Meditech Equity Partners
Ziegler Meditech Equity Partners investment in Venture Round - Aposense
Pontifax
Pontifax investment in Venture Round - Aposense
Pontifax
Pontifax investment in Venture Round - Aposense
Polar Investments
Polar Investments investment in Venture Round - Aposense
Technorov Holdings
Technorov Holdings investment in Venture Round - Aposense
Docor International Management
Docor International Management investment in Venture Round - Aposense
Ziegler Meditech Equity Partners
Ziegler Meditech Equity Partners investment in Venture Round - Aposense
Clal Biotechnology Industries
Clal Biotechnology Industries investment in Venture Round - Aposense
Phoenix Insurance
Phoenix Insurance investment in Venture Round - Aposense
Bargal R&D Investment
Bargal R&D Investment investment in Venture Round - Aposense
Official Site Inspections
http://www.aposense.com Semrush global rank: 8.94 M Semrush visits lastest month: 446
- Host name: mail.aposense.com
- IP address: 185.106.129.182
- Location: Israel
- Latitude: 31.5
- Longitude: 34.75
- Timezone: Asia/Jerusalem
More informations about "Aposense"
Aposense - Interna
Aposense is becoming. Translating the vision of macromolecule therapeutics into a druggable reality. We develop a unique delivery modality for getting DNA, RNA, proteins, peptides, and …See details»
Aposense - LinkedIn
Aposense is an innovative biotechnology company that developed a transformational delivery technology for macromolecules. The pioneering technology, named Molecular Nano-Motors …See details»
Aposense Company Profile 2024: Valuation, Funding
Aposense General Information Description. Developer of diagnostic and therapeutic drugs based in Petah Tikva, Israel. The company is engaged in …See details»
Aposense - Devex
Learn more about Aposense's jobs, projects, latest news, contact information and geographical presence. Professor Kornberg served as a director of Teva Pharmaceutical Industries Ltd. …See details»
About Aposense | Aposense
Aposense is an Israeli publicly-traded biopharmaceutical company (TASE: APOS), specializing in development of novel drugs, based on a proprietary integration of structural and electrical …See details»
Aposense - Contacts, Employees, Board Members, Advisors
Organization. Aposense . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies ... Contacts 4. About. Aposense has 7 current employee …See details»
Aposense Ltd. - Drug pipelines, Patents, Clinical trials - Synapse
Explore Aposense Ltd. with its drug pipeline, therapeutic area, technology platform, 4 clinical trials, 1 news, and 11 literature, Disease Domain:Neoplasms, Endocrinology and Metabolic …See details»
Aposense - Funding, Financials, Valuation & Investors - Crunchbase
Aposense is a molecular imaging and drug development company, with a pipeline of products, based on its apoptosis-based technology. Search Crunchbase. ... How much funding has this …See details»
Aposense - Funding, Financials & Acquisition | Startup Nation Finder
Nov 4, 2024 Note that you need to have an email in this organization in order to claim the profile. Name* Work Email* (please provide your email in the organization) Position* Notes. Send Tap …See details»
Aposence
Aposense® specializes in the development of a unified industry standard for systemic gene delivery. News. 20/10/2016. 19/05/2016. Nomination of Professor Roger D. Kornberg, Nobel …See details»
Aposense - Zefyron Company Profile
Aposense is a molecular imaging and drug development company, with a pipeline of products, based on its apoptosis-based technology.See details»
Aposense - VentureRadar
Aposense for PET, SPECT and MRI based clinical molecular imaging of apoptosis. Therapies based on the targeting of therapeutic agents to apoptosis inflicted tissues. Israel Science and …See details»
Aposense - Crunchbase
Aposense is a molecular imaging and drug development company, with a pipeline of products, based on its apoptosis-based technology.See details»
Aposense - Ziegler
Aposense, Ltd. (fka NeuroSurvival Technologies, Ltd.) has developed a series of molecules that selectively target and accumulate within dying, or apoptotic cells. The molecules, which use …See details»
Aposense Ltd. | Insights
Already A Biomedtracker Subscriber? You have access to the full company record through your subscription.See details»
Apo-si | Aposense
The Technology: For almost two decades now, the Company pioneers in translational R&D, of a recently-discovered, constitutive and extremely powerful electric field (10 7-10 8 V/m !), that …See details»
Publication Archive - Aposense
Damianovich, M., Ziv, I., Heyman, S. N., Rosen, S., Shina, A., Kidron, D., Aloya, T., Grimberg, H., Levin, G., Reshef, A., Bentolila, A., Cohen, A., & Shirvan, A. (2005).See details»
Aposense - Tech Stack, Apps, Patents & Trademarks - Crunchbase
Nov 3, 2024 The intellectual property of Aposense includes 27 registered patents primarily in the ' Medical Or Veterinary Science; Hygiene ' category, according to IPqwery. Additionally, …See details»
Advosense: Smart incontinence management
Disposable incontinence briefs with smart inlay technology and real-time alerts. For the better management of urinary incontinence and bladder control issues.See details»